Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Microbiology Spectrum|July 11, 2023
Comprehensive Genomic Characterization of Staphylococcus aureus Isolated from Atopic Dermatitis Patients in Japan: Correlations with Disease Severity, Eruption Type, and Anatomical SiteShoko Obata, Junzo Hisatsune, Hiroshi Kawasaki, et al.
Medical Oncology (Northwood, London, England)|May 11, 2018
Assessment of the methods used to detect HER2-positive advanced extramammary Paget's diseaseIkuko Hirai, Keiji Tanese, Yoshio Nakamura, et al.
International Journal of Clinical Oncology|September 21, 2021
Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patientsDai Ogata, Keiji Tanese, Yoshio Nakamura, et al.
Journal of Dermatological Science|September 4, 2023
Role of androgen signaling in androgen receptor-positive extramammary Paget's disease: Establishment of organoids and their biological analysis as a novel therapeutic targetYoshio Nakamura, Hayase Mizukami, Keiji Tanese, et al.
The Journal of Dermatology|May 13, 2015
Pathological characterization of pachydermia in pachydermoperiostosisKeiji Tanese, Hironori Niizeki, Atsuhito Seki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2016
Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III MelanomaSuhendan Ekmekcioglu, Michael A Davies, Keiji Tanese, et al.
Journal of Dermatological Science|August 22, 2012
Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype-genotype correlation in Japanese patients with pachydermoperiostosisTakashi Sasaki, Hironori Niizeki, Atsushi Shimizu, et al.
Medicine|October 31, 2020
Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study)Maki Ishii, Ikuko Hirai, Keiji Tanese, et al.
BMC Cancer|March 4, 2026
Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1)Yoshio Nakamura, Naoya Yamazaki, Kenjiro Namikawa, et al.
Nature Communications|October 2, 2023
Multifaceted analysis of cross-tissue transcriptomes reveals phenotype-endotype associations in atopic dermatitisAiko Sekita, Hiroshi Kawasaki, Ayano Fukushima-Nomura, et al.
Pageof 6